Fig. 1
The number of tocilizumab-induced hypofibrinogenemia. a Number of hypofibrinogenemia cases after tocilizumab treatment. b Number of hypofibrinogenemia cases in grade 1–4. c Number of bleeding cases
Fig. 1 | BMC Pharmacology and Toxicology